Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Urowitz

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Arthritis Care & Research|May 14, 2014
Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomesHesham Al Maimouni, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|February 4, 2003
Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvementHermine I Brunner, Brian M Feldman, Murray B Urowitz, et al.
The Journal of Rheumatology|December 1, 2020
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus NephritisKonstantinos Tselios, Dafna D Gladman, Cameron Taheri, et al.
The Journal of Rheumatology|January 17, 2015
Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activityJonathan Y C Ding, Dominique Ibañez, Dafna D Gladman, et al.
The Journal of Rheumatology|November 3, 2017
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective StudyKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|April 25, 2018
A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid indexZahi Touma, Dafna D Gladman, Jiandong Su, et al.
The Journal of Rheumatology|November 17, 2010
Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over timeDominique Ibañez, Dafna D Gladman, Zahi Touma, et al.
The Journal of Rheumatology|December 5, 2006
Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depressionAndrea Iaboni, Dominique Ibanez, Dafna D Gladman, et al.
The Journal of Rheumatology|June 17, 2015
SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall ImprovementZahi Touma, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|November 3, 2020
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysisKonstantinos Tselios, Laura Wakani, Dafna D Gladman, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Arthritis Care & Research|May 14, 2014
Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomesHesham Al Maimouni, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|February 4, 2003
Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvementHermine I Brunner, Brian M Feldman, Murray B Urowitz, et al.
The Journal of Rheumatology|December 1, 2020
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus NephritisKonstantinos Tselios, Dafna D Gladman, Cameron Taheri, et al.
The Journal of Rheumatology|January 17, 2015
Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activityJonathan Y C Ding, Dominique Ibañez, Dafna D Gladman, et al.
The Journal of Rheumatology|November 3, 2017
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective StudyKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|April 25, 2018
A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid indexZahi Touma, Dafna D Gladman, Jiandong Su, et al.
The Journal of Rheumatology|November 17, 2010
Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over timeDominique Ibañez, Dafna D Gladman, Zahi Touma, et al.
The Journal of Rheumatology|December 5, 2006
Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depressionAndrea Iaboni, Dominique Ibanez, Dafna D Gladman, et al.
The Journal of Rheumatology|June 17, 2015
SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall ImprovementZahi Touma, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|November 3, 2020
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysisKonstantinos Tselios, Laura Wakani, Dafna D Gladman, et al.
Pageof 19